Maximilian Hochmair

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Maximilian Hochmair

Oct 31, 2024, 09:03 | Insight

Jarushka Naidoo: Maintenance Pembrolizumab with or without Olaparib for Advanced Squamous NSCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about…

Aug 16, 2024, 14:13 | Insight

OS rates for IMpower133 and IMbrella A extension study in SCLC

Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…

Aug 14, 2024, 07:04 | Insight

ES-SCLC 5-year survival outcomes inIMpower133 and IMbrella study

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X, about recent paper…

Aug 14, 2024, 01:53 | Insight

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…

All: 4 Posts: 1 - 100

ASCO GI 2025 - Everything You Need To Know About Biggest Gastrointestinal cancer Symposium

Side Effects of Radiotherapy: Risks and What to Know

Isabel Rubio has been elected as the President of the European Cancer Organisation for 2026-2027

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023